Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-21-057275
Date:2021-09-21
Issuer: IMPEL NEUROPHARMA INC (IMPL)
Original Submission Date:

Reporting Person:

SHREWSBURY STEPHEN B
C/O IMPEL NEUROPHARMA, INC.
201 ELLIOTT AVE. W, ST. 260 SEATTLE, WA 98119

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-09-21 M 14,780 a $1.97 14,780 direct
COMMON STOCK 2021-09-21 M 4,650 a $2.46 19,430 direct
COMMON STOCK 2021-09-21 M 53,954 a $2.95 73,384 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 1.97 2021-09-21 deemed execution date M 14,780 (d) 2027-10-17 common stock 14,780 $1.97 0 direct
STOCK OPTION (RIGHT TO BUY) 2.46 2021-09-21 deemed execution date M 4,650 (d) 2028-03-08 common stock 4,650 $2.46 541 direct
STOCK OPTION (RIGHT TO BUY) 2.95 2021-09-21 deemed execution date M 53,954 (d) 2029-02-07 common stock 53,954 $2.95 29,587 direct
Footnotes
IDfootnote
f1 the option is 100% vested and exercisable.
f2 the option vested as to 25% of the total shares on february 13, 2019, then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested and exercisable on february 13, 2022, subject to the reporting person's provision of service to the issuer on each vesting date.
f3 the option vested as to 25% of the total shares on february 8, 2020, then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested and exercisable on february 8, 2023, subject to the reporting person's provision of service to the issuer on each vesting date.
WhaleWisdom Logo

Elevate your investments